Australia - English - Department of Health (Therapeutic Goods Administration)

horaeco health pty ltd - alpha lipoic acid,ascorbic acid,betacarotene,brassica oleracea var. italica,curcuma longa,cynara scolymus,d-alpha-tocopheryl acid succinate,silybum marianum,taraxacum officinale -

Australia - English - Department of Health (Therapeutic Goods Administration)

horaeco health pty ltd - alpha lipoic acid,ascorbic acid,betacarotene,brassica oleracea var. italica,curcuma longa,cynara scolymus,d-alpha-tocopheryl acid succinate,silybum marianum,taraxacum officinale -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

production agriscience (australia) pty ltd - penthiopyrad - suspension concentrate - penthiopyrad carboximide active 200.0 g/l - fungicide - almond | amsoi | apple | apricot | beetroot | brassica vegetables | broccoli | brussels sprouts | cabbage | capsicum or pepper | - apple scab | botrytis | brown rot - monilinia spp. | early blight (target spot) | early blight or target blackspot | freckle or scab on stone fruit | grey mould - botrytis cinerea | gummy stem blight - didymella bryoniae | pear scab | powdery mildew - erysiphe cichoracearum | powdery mildew - leveillula taurica | powdery mildew - oidium or erysiphe spp. | powdery mildew - podosphaera leucotricha | powdery mildew - sphaerotheca spp. | powdery mildew on cucurbit | purple blotch | sclerotinia rot | white mould rot | black spot | blossom blight | botrytis blight | botrytis rot | bunch rot | bunch rot-grey mould | freckle (scab) | fructicola | grey mould | grey mould (nesting) | sclerotinia flower blight | sclerotinia fungal disease | sclerotinia root rot | sclerotinia soil fungus | soil fungi | sphaerotheca fuliginea | storage rot | target spot | white mould | wilt - sclerotinia

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - prothioconazole; tebuconazole - suspension concentrate - prothioconazole triazole active 210.0 g/l; tebuconazole triazole active 210.0 g/l - fungicide - barley | canola | oats | pyrethrum | triticale | wheat | pellitory | rapeseed | spanish chamomile - blackleg | fusarium spp. | leaf rust | leaf rust - puccinia hordei | leaf scald - suppression | mycosphaerella or ray blight | net form of net blotch | powdery mildew - bulmeria graminis | sclerotinia rot | sclerotinia wilt or stem rot | septoria leaf blotch - suppession | septoria nodorum blotch on wheat | spot form net blotch - pyrenophora teres | stem rust | stripe rust | yellow leaf spot on wheat | fusarium patch | pink rot | post-harvest rot | puccinia recondita f.sp. triti | puccinia triticina | sclerotinia flower blight | sclerotinia fungal disease | sclerotinia nest | sclerotinia root rot | sclerotinia rot | sclerotinia soil fungus | seedling infections | soil fungi | watery soft rot | wheat leaf rust | white mould | wilt - sclerotinia | yellow rust | yellow spot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

everris australia pty ltd - mancozeb; thiophanate-methyl - wettable powder - mancozeb carbamate-dithiocarbamate active 640.0 g/kg; thiophanate-methyl thiourea active 156.0 g/kg - fungicide - african violet | azalea | begonia | carnation | chrysanthemum or tanacetum | dahlia | fern | geranium | gladiolus | hollyhock | - alternaria leaf spot - a. cucumerina | black spot on rose - diplocarpon rosae | blight | botrytis leaf spot or corm collar rot | downy mildew - peronospora spp. | fungus | grey mould - botrytis cinerea | leaf blight | leaf spot - alternaria cercospora | petal blight | powdery mildew | powdery mildew - erysiphe cichoracearum | powdery mildew - oidium spp. | powdery mildew on rose | rust | rust - puccinia antirrhini | rust - puccinia chrysanthemi | rust - puccinia pelargonii-zonalis | rust - uromyces dianthi | septoria leaf spot - septoria apiicola | white rust | azalea | botrytis blight | botrytis rot | bunch rot | celery leaf spot | fungal leaf spots | fungi | fungus diseases | late blight | leaf blight - a. cucumerina | leaf blight - s. apiicola | leaf spot diseases | leaf spots

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

2022 environmental science au pty ltd - trifloxystrobin; tebuconazole - suspension concentrate - trifloxystrobin strobiluron active 100.0 g/l; tebuconazole triazole active 200.0 g/l - fungicide - turf - anthracnose | brown patch | curvularia leaf spot | dollar spot | helminthosporium disease | leptosphaerulina leaf spot | soil borne fungi - refer to label | spring dead spot | winter fusarium | bipolaris spp. | drechslera dermatiodia | drechslera spp. | exserohilum spp. | fusarium spp. | helminthosporium disease patch | helminthosporium leaf spot | helminthosporium spot | helminthosporium spp. | leaf blight - helminthosporium | rhizoctonia spp. | white helminthosporium

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 100 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; calcium hydrogen phosphate; lactose monohydrate; hyprolose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 100 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; lactose monohydrate; croscarmellose sodium; calcium hydrogen phosphate; hyprolose; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; calcium hydrogen phosphate; magnesium stearate; colloidal anhydrous silica; hyprolose; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 70 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; lactose monohydrate; hyprolose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.